Analyst Activity – Leerink Swann Reiterates Outperform on AstraZeneca plc (NYSE:AZN)

23

Analyst Ratings For AstraZeneca plc (NYSE:AZN)

Today, Leerink Swann reiterated its Outperform rating on AstraZeneca plc (NYSE:AZN).

There are 1 sell rating, 5 hold ratings, 11 buy ratings on the stock.

The current consensus rating on AstraZeneca plc (NYSE:AZN) is Buy (Score: 2.59) with a consensus target price of $37.79 per share, a potential 23.09% upside.

Some recent analyst ratings include

  • 3/20/2017-Leerink Swann Reiterated Rating of Outperform.
  • 3/9/2017-Liberum Capital initiated coverage with a Buy rating.
  • 3/7/2017-Barclays PLC initiated coverage with a Overweight rating.
  • 3/6/2017-Cowen and Company Reiterated Rating of Market Perform.
  • 2/21/2017-Berenberg Bank Reiterated Rating of Buy.
  • 12/13/2016-JPMorgan Chase & Co. Reiterated Rating of Neutral.
  • 11/11/2016-Deutsche Bank AG Reiterated Rating of Buy.

Dividend information for AstraZeneca plc (NYSE:AZN)

AstraZeneca plc (NYSE:AZN) pays an annual dividend of $1.37 with a yield of 4.46% and an average dividend growth of -21.20% based on a 3 Year Average..

Dividend History for AstraZeneca plc (NYSE:AZN)

  • On 2/3/2017 AstraZeneca plc announced a semiannual dividend of $0.95 6.81% with an ex dividend date of 2/15/2017 which will be payable on 3/20/2017.
  • On 7/29/2016 AstraZeneca plc announced a dividend of $0.44 with an ex dividend date of 8/10/2016 which will be payable on 9/12/2016.
  • On 2/5/2016 AstraZeneca plc announced a dividend of $0.93 with an ex dividend date of 2/17/2016 which will be payable on 3/21/2016.
  • On 2/10/2015 AstraZeneca plc announced a semiannual dividend of $1.90 5.57% with an ex dividend date of 2/18/2015 which will be payable on 3/23/2015.
  • On 8/1/2014 AstraZeneca plc announced a semiannual dividend of $0.90 2.48% with an ex dividend date of 8/13/2014 which will be payable on 9/15/2014.
  • On 2/10/2014 AstraZeneca plc announced a special dividend of $1.90 2.79% with an ex dividend date of 2/19/2014 which will be payable on 3/24/2014.
  • On 8/2/2013 AstraZeneca plc announced a semiannual dividend of $0.90 3.52% with an ex dividend date of 8/14/2013 which will be payable on 9/16/2013.


    About AstraZeneca plc (NYSE:AZN)
    AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in various therapy areas, including respiratory, inflammation, autoimmune disease (RIA), cardiovascular and metabolic disease (CVMD) and oncology, as well as in infection, neuroscience and gastrointestinal areas. The Company has its operations in over 100 countries. The Company’s pipeline includes over 150 projects of which approximately 125 are in the clinical phase of development. The Company is developing a Toll-like receptor 9 (TLR-9) receptor agonist aimed at producing long-term benefit in asthma by addressing imbalances in the immune system. AstraZeneca offers various products, including Accolate, Rhinocort, Bricanyl Turbuhaler, Rhinocort, Symbicort pMDI, Crestor, Seloken/Toprol-XL, Brilinta/Brilique (ticagrelor), Bydureon, Xigduo XR, Kombiglyze XR and metformin XR, among others.

    Recent Trading Activity for AstraZeneca plc (NYSE:AZN)
    Shares of AstraZeneca plc closed the previous trading session at 30.70 up +0.01 0.03% with 3,443,903 shares trading hands.

    An ad to help with our costs